Omalizumab improves asthma-related quality of life in patients with severe allergic asthma.

@article{Finn2003OmalizumabIA,
  title={Omalizumab improves asthma-related quality of life in patients with severe allergic asthma.},
  author={Albert F Finn and Gary Gross and Julius H van Bavel and Theodore K. Lee and Hugh H Windom and François Everhard and Angel Fowler-Taylor and Jeen Liu and Niroo Gupta},
  journal={The Journal of allergy and clinical immunology},
  year={2003},
  volume={111 2},
  pages={278-84}
}
BACKGROUND We have previously shown that omalizumab, a recombinant humanized monoclonal anti-IgE antibody, reduces asthma exacerbations and decreases inhaled corticosteroid (ICS) requirement in patients with severe allergic asthma who were symptomatic despite moderate-to-high doses of ICSs. OBJECTIVE The aim of the present study was to assess the effects of omalizumab on asthma-related quality of life (QOL). METHODS These analyses were part of a multicenter, 52-week, randomized, double… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Similar Papers

Loading similar papers…